News Select Year All Years 2025 (35) 2024 (31) 2023 (31) 2022 (35) 2021 (28) 2020 (36) 2019 (46) 2018 (51) 2017 (34) 2016 (26) 2015 (42) 2014 (30) 2013 (26) 2012 (23) 2011 (28) 2010 (36) 2009 (39) 2008 (55) 2007 (50) Clinical Trials Select Clinical Trial AWARE-1 (20) BRACELET-1 (10) GOBLET (32) Search … May 6, 2016 Oncolytics Biotech® Inc. Announces 2016 First Quarter Results May 6, 2016 Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders May 5, 2016 Oncolytics Biotech® Inc. Announces Presentation of REOLYSIN® Preclinical Research at the 2016 ASGCT Annual Meeting May 3, 2016 Oncolytics Biotech® Inc. Announces Details of 2016 Annual Meeting of Shareholders April 29, 2016 Oncolytics Biotech® Inc. Announces Formation of Science and Technology Committee April 29, 2016 Oncolytics Biotech® Inc. to Participate in the Bloom Burton & Co. Healthcare Investor Conference April 18, 2016 Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Research at the 2016 AACR Annual Meeting April 14, 2016 Oncolytics Biotech® Inc. Reports Updated Data from Randomized Phase 2 Study of REOLYSIN® in Pancreatic Cancer March 24, 2016 Oncolytics Biotech® Inc. Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting March 21, 2016 Oncolytics Biotech® Inc. Reports Data from Randomized Phase 2 Study of REOLYSIN® in Ovarian Cancer Newer Page 35 of 69 Older